Inclusion Criteria:
  -  A coded inpatient or outpatient T2DM diagnosis (ICD9/ICD10) and an antidiabetic medication prescription within the 90 days following the diagnosis date (CP1); a coded T2DM diagnosis and an outpatient glycolated hemoglobin (HbA1C) value≥6.5% within 90 days before or after the diagnosis date (CP2); or any antidiabetic medication prescription within 90 days before or after an outpatient HbA1C value ≥6.5% (CP3).
  -  New use of a medication of interest (metformin, sulfonylurea, DPP4 inhibitor, SGLT2 inhibitor, or GLP1 receptor agonist
  -  Estimated glomerular filtration rate (eGFR) of less than 60 ml/min within the month prior to the new medication
Exclusion Criteria:
  -  Coded diagnoses of gestational diabetes
  -  Coded diagnoses of prediabetes
  -  Coded diagnoses of type 1 diabetes
  -  Evidence of a positive beta human chorionic gonadotropin test as a marker for pregnancy during the 90 days before or after the index date